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Purpose: Cognitive impairment is common in older people admitted to hospital, but the out-
comes are generally poorly understood, and previous research has shown inconsistent associa-
tions with mortality depending on the type of cognitive impairment examined and duration of 
follow-up. This study examines mortality in older people with any cognitive impairment during 
acute hospital admission.
Patients and methods: Prospective cohort of 6,724 people aged ≥65 years with a structured 
cognitive assessment on acute admission were included in this study. Cognitive spectrum disorder 
(CSD) was defined as delirium alone, known dementia alone, delirium superimposed on known 
dementia, or unspecified cognitive impairment. Mortality associated with different types of CSD 
was examined using a non-proportional hazards model with 2-year follow-up.
Results: On admission, 35.4% of patients had CSD, of which 52.6% died within 2 years. After 
adjustment for demographics and comorbidity, delirium alone was associated with increased 
mortality in the 6 months post-admission (HR =1.45, 95% CI 1.28–1.65) and again after 1 year 
(HR =1.44, 95% CI 1.17–1.77). Patients with known dementia (alone or with superimposed 
delirium) had increased mortality only after 3 months from admission (HR =1.85, 95% CI 
1.56–2.18 and HR =1.80, 95% CI 1.52–2.14) compared with patients with unspecified cogni-
tive impairment after 6 months (HR =1.55, 95% CI 1.21–1.99). Similar but partially attenuated 
associations were seen after adjustment for functional ability.
Conclusion: Mortality post-admission is high in older people with CSD. Immediate risk is 
highest in those with delirium, while dementia or unspecified cognitive impairment is associated 
with medium- to long-term risk. These findings suggest that individuals without dementia who 
develop delirium are more seriously ill (have required a larger acute insult in order to precipitate 
delirium) than those with pre-existing brain pathology (dementia). Further research to explain 
the mortality patterns observed is required in order to translate the findings into clinical care.
Keywords: acute admission, elderly, cognition, function, non-proportional hazards
Introduction
The rising prevalence of cognitive impairment driven by rapid population aging is a 
growing public health concern and presents major challenges to all health services, 
including hospitals. Cognitive impairment has been reported to be present in 26%1 to 
47.9%2 of hospitalized older people, with varying prevalence depending on the popula-
tion studied (eg, specialist settings vs unselected medical admissions, age range) and 
the assessment methods used.
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Cognitive impairment in hospital inpatients can be due 
to a number of overlapping conditions.3,4 People may have 
known dementia before admission, may develop delirium due 
to an acute illness precipitating admission, may have delirium 
superimposed on known dementia, or may have unspecified 
cognitive impairment defined as impaired cognition without 
a formal diagnosis of dementia or delirium. We have recently 
proposed the term “cognitive spectrum disorder” (CSD) to 
include any of these forms of cognitive impairment.5 Older 
people admitted to hospital with a CSD are a heterogeneous 
and highly vulnerable population. Due to overlapping symp-
toms, differentiation between the different types of CSD in 
clinical settings can be difficult. In general it is known that 
they have poor outcomes in terms of longer hospital stay6,7 
and higher associated costs.8
People with various individual CSDs have been shown 
to have a high mortality in many studies internationally.9–15 
A US population study reported that 39.6% of older people 
with dementia had died by the end of 6.5 years follow-up, 
compared to 18.5% of people without dementia.10 Mortal-
ity rates are particularly high in hospitalized people with 
CSD.2,16–19 Sampson et al estimated a 24% in-hospital mortal-
ity rate in people with dementia aged ≥70 years,2 and Fick 
et al reported 25% mortality within a month of admission 
in older people with delirium superimposed on dementia.17 
A recent study investigating mortality of hospitalized older 
people in Brazil found an in-hospital mortality rate of 32% 
in people with delirium superimposed on dementia on admis-
sion and 29% in people with delirium alone, as opposed to 
12% in people with dementia alone and 8% in those without 
delirium or dementia.19 For those surviving to discharge, 
mortality in the subsequent year in those with dementia 
was significantly higher than that in those with delirium 
alone (43.9% vs 36.2%). This evidence suggests that post-
admission mortality risk in patients with CSD may vary over 
time depending on the underlying condition. However, most 
of the previous research studies have examined only some 
CSD conditions, using relatively small cohorts of selected 
volunteers in specialist geriatric medicine settings with vari-
able lengths of follow-up. It is difficult to be sure whether the 
varying findings of different studies reflect true differences 
in mortality in different settings or simply patient selection 
and analytical choices.
We can hypothesize that patients with any CSD are at 
increased risk of death and that associated physical illness 
severity (the precipitant of delirium) results in increased early 
risk of death. In addition, the presence of CSD in older people 
is strongly correlated with low functional ability, which in 
itself is associated with poor outcomes following hospital 
admission.16,19,20 However, whether the CSD associated 
functional impairment can fully explain the poor outcomes in 
people with CSD admitted to hospital is not well understood.
Aim
The aim of this study was to use a large population-based 
data set of older people admitted to hospital to examine the 
mortality risks associated with different types of CSD up to 2 
years after hospital admission adjusted for known confound-
ers including patients’ functional ability.
Materials and methods
Population
This is a prospective cohort study of people aged ≥65 years 
admitted as a medical emergency between January 1, 2012 
and December 31, 2013, with 2-year follow-up, using linked 
national data.
NHS Fife provides care to a varied urban and rural 
population of ~360,000. During the study, all emergency 
medical admissions were via a single acute medical unit 
(AMU) in a 640-bedded district general hospital. Trained 
specialist nurses assessed people aged 65+ years on admis-
sion using a locally developed Older Persons Routine Acute 
Assessment (OPRAA) based on the principles of compre-
hensive geriatric assessment.21 OPRAA was completed in 
the first 24 hours of admission, and by design, individuals 
expected to die because terminally ill or transferred to 
critical care or with a predicted length of stay <24 hours 
were not assessed.
An incident cohort was defined as those aged 65+ years 
who had received an OPRAA assessment during the 2-year 
study period and had no previous acute medical admission 
in the prior 6 months. The incident cohort aimed to identify 
individuals at the beginning of a new interaction with acute 
hospital services and follow them through their subsequent 
care capturing all re-admissions and mortality. We used clini-
cal judgment to define this, with a consensus that a patient 
with no admissions in the previous 6 months was starting a 
new interaction.
Data and covariates
Data for all eligible incident admissions were identified from 
the Scottish Morbidity Records 01 (SMR01) data, which is a 
validated NHS Scotland routine data set recording admission 
and discharge dates and destinations, and discharge diag-
nosis using ICD-10 codes. Discharge diagnosis (excluding 
dementia) from all previous admissions was used to calculate 
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each participant’s Charlson Comorbidity Index (CCI) on 
admission.22
The OPRAA data set was used to identify patients with 
an OPRAA assessment completed, which recorded CSD 
(with the following groups: delirium alone, dementia alone, 
delirium superimposed on known dementia, and unspeci-
fied cognitive impairment in the absence of delirium and/or 
dementia; Box 1) and functional status based on assessment 
of activities of daily living (ADL with the following groups: 
persistently low ADL and changed ADL; Box 1).
Data on all community dispensed prescriptions were used 
to create an additional multimorbidity score, calculated as 
the number of drugs (defined as number of distinct British 
National Formulary subsections) prescribed to the patient 84 
days prior to admission.23
All patients were followed up from the date of their index 
admission to the earliest of their date of death or 2 years 
follow-up. Death was ascertained from the Community 
Health Index data set (CHI – the NHS Scotland population 
register), which was also used to define participant age, sex, 
and postcode-defined socioeconomic status (measured using 
quintiles of the Scottish Index of Multiple Deprivation) on 
admission.26
The CHI number (the NHS Scotland unique patient 
identifier) was used to deterministically link SMR01 to CHI, 
OPRAA, SMR04, and community dispensed prescribing.
Missing data
Data on delirium diagnosis was missing in 3.7% of cases 
in the incident cohort. Based on OPRAA alone, 9.8% of 
cases were recorded as having known dementia and 20.3% 
of cases had missing data for dementia. After adding infor-
mation on dementia from SMR01, SMR04, and prescribing 
data sets, the percentage of people with known dementia 
was 15.3%, with the rest of cases being treated as absence 
of dementia. 20.9% of cases had a missing AMT score 
within OPRAA, of which 15.5% had neither delirium nor 
dementia; these were classified as not having any CSD. 
27% of ADL scores within OPRAA had missing values. 
Multiple imputation based on PROC MI in SAS was used 
to impute the missing ADL categories based on five impu-
tations and assuming data were missing at random.27 The 
imputation model for missing ADL status was based on the 
logistic regression and included all the variables used in 
the survival model (sex, age, deprivation status, residential 
status, comorbidity, and number of drugs 84 days prior to 
admission), as well as outcome variables that were thought 
to be predictive of the missing ADL values such as length 
of hospital stay, mortality at 1 month, 3 months, 6 months, 
1 year, and 2 years. A pooled analysis of the five imputed 
data sets using PROC MIANALYSE in SAS was performed 
as main analysis, and a sensitivity analysis was carried out 
on the complete ADL cases.
Statistical analysis
Summary statistics based on numbers and the corresponding 
proportions for categorical variables and mean with standard 
deviations for continuous variables were used to describe 
prevalence of the different CSDs in older people admitted to 
AMU and how this varied with their demographics. Charac-
teristics of older people in the CSD groups were examined 
in terms of CCI (with groups: zero, one, two to five and six 
and over), number of drugs 84 days prior to admission (with 
groups: zero drugs, one to five drugs, six to ten drugs, and 
Definitions of cognitive spectrum disorder
Delirium was defined as a clinical diagnosis of delirium made by 
the trained specialist nurse completing the OPRAA.8 OPRAA 
included administration of the Confusion Assessment Method 
(CAM) using the original (pre-2014) recommended scoring24 which 
was subsequently revised to address low sensitivity in clinical 
applications, so for the purposes of this analysis we used the overall 
clinical assessment made by the trained nurses. 
Known dementia was defined as documentation during the OPRAA 
assessment of the presence of a preadmission diagnosis of dementia 
from self/informant report and/or hospital and primary care 
records; OR a prior iCD-10 code for dementia recorded during an 
acute hospital (SMR01) or psychiatric admission (SMR04); OR prior 
community prescribing of a drug for dementia (anticholinesterase 
inhibitors or memantine as listed in British National Formulary, 
chapter 4.11). 
Delirium superimposed on dementia was defined as the presence of 
delirium in a patient with known dementia. 
Unspecified cognitive impairment was defined as an Abbreviated 
Mental Test (AMT) score <8 in people with no delirium and no 
known dementia.8
Categorization of functional status
Functional status was assessed during OPRAA using the activities of 
daily living (ADL) assessment of six basic activities: eating, bathing, 
dressing, toileting, transferring (walking), and continence adding 
up to a maximum score of 6.25 Based on patient and/or informant 
report, functional status was assessed at 12 weeks before admission 
(pre-ADL) and on admission (current-ADL) based on direct 
observation. Participants were then defined as having:
•	 Persistently low-ADL (pre-ADL score <5 all of whom had 
current-ADL <5)
•	 Changed-ADL group (pre-ADL score ≥5 and current-ADL score 
<5)
•	 Persistently high-ADL (both pre- and current-ADL scores ≥5).
Box 1 Definitions of cognitive spectrum disorder and 
categorization of functional status
Abbreviation: OPRAA, Older Persons Routine Acute Assessment. 
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eleven and more), and ADL function (persistently low-ADL, 
changed-ADL group, or persistently high-ADL; Box 1).
Analysis of time to death with a 2-year follow-up from 
admission was initially assessed with Kaplan–Meier survival 
plots with the corresponding mortality rates. Cox propor-
tional hazards models using PROC PHREG in SAS were 
initially used to investigate the association of CSDs and 
survival. Assessment of the proportional hazards assumption, 
derived from the cumulative sum of martingale residuals 
and Kolmogorov-type supremum test using the ASSESS 
statement under PROC PHREG,28 showed that some of 
Cox model covariates did not meet this assumption, so a 
non-proportional hazards model with time-varying coeffi-
cients was fitted.29 Time-varying coefficients were modeled 
based on a piecewise constant model function, where the 
2-year follow-up was initially split into five time intervals: 
up to 1 month (implemented as up to 30 days), 1–3 months 
(31–90 days), 3–6 months (91–180 days), 6 months to 1 
year (181–365 days), and 1–2 years (366–730 days). The 
Akaike’s Information Criteria (AIC) was used to optimally 
choose the time points (among 30, 90, 180, and 365 days) 
when a change in HR was supported by the data, if no change 
in HR between consecutive time periods was supported by 
the data, then these periods were re-grouped and an HR 
was calculated for the re-grouped time period. The effect of 
CSD on survival was estimated in terms of unadjusted HRs 
(unadjusted model a) and HRs adjusted for demographics 
and comorbidity variables (adjusted model b). Additionally, 
HRs adjusted further for ADL functional status (adjusted+ 
ADL model c) were calculated to specifically determine how 
much of the increase in hazard ratio in people with CSDs was 
explained by their functional status. The AIC was used for 
variable selection in the adjusted models b and c.
Finally, to test for a difference in mortality risks between 
delirium superimposed on dementia and delirium alone, 
delirium superimposed on dementia and dementia alone, 
and unspecified cognitive impairment and dementia alone, 
the non-proportional hazards model was repeatedly fitted 
by changing the reference category with the different CSD 
categories instead of the No-CSD category.
Data analysis was carried out using SAS® 9.4 (SAS 
Institute Inc., Cary, NC, USA).
Ethical approval
Data provision and initial management including linkage 
was carried by the University of Dundee Health Informatics 
Centre (HIC, https://www.dundee.ac.uk/hic), with analysis 
of anonymized data carried out in an ISO27001 and Scottish 
Government accredited secure safe haven. HIC Standard 
Operating Procedures have been reviewed and approved 
by the NHS East of Scotland Research Ethics Service, and 
consent for this study was obtained from the NHS Fife Cal-
dicott Guardian.38
Results
Description of the cohort
Between January 2012 and December 2013, there were 
17,151 admissions of patients aged ≥65 years to the AMU. 
About 9,331 of these admissions were incident admissions, 
of which 6,724 (72%) had an OPRAA. The mean age for 
patients in the incident OPRAA cohort was 79.2 years, 
56.3% were women, and 7.4% were admitted from a care 
home. About 20.5% of patients lived in the most deprived 
fifth of areas, whereas 14.6% lived in the most affluent fifth.
CSD was present in 35.4% of the incident OPRAA admis-
sions. Delirium alone was present in 15.8%, known dementia 
alone in 7.8%, delirium superimposed on dementia in 7.6%, 
and unspecified cognitive impairment in 4.2% of admissions.
People with CSD were older than those without (Table 
1, mean age 82.1 vs 77.6 years) and 59.2% of patients with 
CSD were women vs 54.6% of those without. About 17.9% 
of people with CSD were admitted from a care home vs only 
1.7% of those without with 29.9% of people with dementia 
alone and 34.1% of people with delirium superimposed on 
dementia residing in a care home (Table S1). We considered 
all these differences large enough to potentially influence 
any observed association between CSDs and mortality. There 
were no major differences by socioeconomic deprivation.
In general, the presence of any CSD was strongly asso-
ciated with low functional ability with 81.0% of patients 
with CSD having a persistently low-ADL or changed-ADL, 
compared to 41.8% of patients without a CSD patterns of 
ADL varied by CSD, with over 50% of patients with known 
dementia having a persistently low-ADL, whereas almost 
50% of patients admitted with delirium alone had a changed-
ADL at admission (Table S1).
Survival analysis
Kaplan–Meier survival curves for the different subgroups of 
patients and the associated mortality rates are presented in 
Figure 1 and Table S2. Mortality was higher in patients with 
CSD with 52.6% dying within the 2-year follow-up com-
pared to 33.5% of those without (Figure 1A). Increasing age 
was associated with lower survival (Figure 1B), as was sex, 
with men being at higher risk (Figure 1C). There was poorer 
survival for people admitted from a care home than private 
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home (Figure 1D, 74.6% vs 37.5% 2-year mortality rate) and 
people with a high comorbidity index (CCI 6+) also had a 
very poor survival (Figure 1E, 83.2% 2-year mortality rate). 
Survival in patients with persistently low-ADL was generally 
poor with 62.9% of this group of patients dying within the 
2-year follow-up time, the corresponding figures for those 
with a changed-ADL and persistently high-ADL being 45.6% 
and 28.4% (Figure 1F). The results of the Cox proportional 
hazards model are shown in Table S3. However, the assump-
tion of proportional hazards over time was violated for several 
variables indicating that the Cox model was misspecified.
The non-proportional hazards model results showing 
changes over time in the HR estimates associated with the 
different types of CSD are illustrated in Figure 2. Unadjusted 
HR estimates of the non-proportional hazards model (Table 
2, model a) showed that, compared to patients without CSD, 
patients with delirium alone had a higher risk of death in 
the first 6 months from admission and again after 1 year, 
whereas risk of death in patients with dementia (alone or with 
delirium superimposed) was increased in the first 3 months 
and further increased over longer follow-up. For patients 
with unspecified cognitive impairment, the risk of death was 
increased throughout follow-up compared to those without 
CSD. All other modeled variables apart from the number of 
drugs showed significant associations with mortality in all 
or most time periods.
Table 1 Characteristics of people with CSD vs without CSD in terms of sex, age, residential status, deprivation, comorbidities, and 
functional status
No CSDs Any CSDs
All patients (N=6,724) (N=4,344) (N=2,380)
Sex
Female (N=3,784) 2,375 (54.6) 1,409 (59.2)
Age (years), mean (SD) 77.6 (7.7) 82.1 (7.7)
65–69 (N=955) 788 (18.1) 167 (7)
70–74 (N=1,123) 867 (20.0) 256 (10.8)
75–79 (N=1,322) 902 (20.8) 421 (17.7)
80–84 (N=1,420) 871 (20.1) 549 (23.1)
85+ (N=1,904) 916 (21.1) 988 (41.5)
Residential status
Care home (N=500) 75 (1.7) 425 (17.9)
SiMDa
1, most deprived (N=1,376) 919 (21.2) 456 (19.2)
2 (N=1,789) 1,136 (26.1) 653 (27.4)
3 (N=1,548) 983 (22.6) 565 (23.7)
4 (N=1,032) 654 (15.1) 378 (15.9)
5, least deprived (N=979) 652 (15) 327 (13.7)
CCi groupsb
CCi 0 (N=1,629) 992 (22.8) 647 (27.2)
CCi 1 (N=1,728) 1,152 (26.5) 576 (24.2)
CCi 2–5 (N=2,733) 1,756 (40.4) 977 (41.1)
CCi 6+ (N=624) 449 (10.2) 180 (7.6)
No. of drugsc
0 (N=389) 227 (5.2) 162 (6.8)
1–5 (N=1,725) 1,108 (25.5) 617 (25.9)
6–10 (N=2,650) 1,726 (39.7) 924 (38.8)
10+ (N=1,960) 1,283 (29.5) 677 (28.5)
ADL groups (N=4,846)a (n=2,871) (n=1,975)
Persistently low ADL (N=1,144) 314 (10.9) 830 (42.0)
Changed ADL (N=1,656) 886 (30.9) 770 (39.0)
Persistently high ADL (N=2,046) 1,671 (58.2) 375 (19.0)
Notes: All data are represented as n (%) except where indicated. aScottish Index of Multiple Deprivation divided into five quintiles. bCharlson Comorbidity Index groups 
based on ICD10 codes in SMR01 data set. cNumber of drugs prescribed during the 84 days prior to admission. dADL based on current and 3 months prior to admission, 
27% of which are missing.
Abbreviations: CSD, cognitive spectrum disorder; ADL, activity of daily living; CCI, Charlson Comorbidity Index; SIMD, Scottish Index of Multiple Deprivation.  
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After adjustment for demographics and comorbidity, similar 
patterns of mortality risk over time persisted for people with 
CSD (Table 2, model b). Patients with delirium alone were at 
an increased risk of death compared to those without CSD in 
the first 6 months post-admission (HR 1.45, 95% CI 1.28–1.65) 
and between 1 and 2 years after admission (HR 1.44, 95% CI 
1.17–1.77). Patients with dementia (with or without superim-
posed delirium) were at an increased risk after 3 months from 
admission (HR 1.85, 95% CI 1.56–2.18 and HR 1.80, 95% CI 
1.52–2.14 respectively), and patients with unspecified cognitive 
impairment had an increased risk of death only after 6 months 
from admission (HR 1.55, 95% CI 1.21–1.99).
Patients’ sex, age, care home residence, and CCI were 
significantly associated with mortality with non-constant 
HRs providing a better fit over the 2-year follow-up (Table 
S4, model b). In the adjusted model, associations with the 
numbers of drugs dispensed were weaker and less consistent, 
and social deprivation was found not significant and removed 
from the model.
Patients with persistently low-ADL and changed-ADL 
were at higher risk of death in the first month following admis-
sion compared to those with persistently high-ADL (Table S4, 
model c, persistently low-ADL HR 2.26 , 95% CI 1.74–2.94 
and changed-ADL HR 2.31 95% CI 1.81–2.96). These associa-
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Figure 1 Kaplan–Meier survival functions for the CSD groups (A), age groups (B), sex (C), residential status (D), CCi groups (E), and ADL functional status (F).
Abbreviations: CSD, cognitive spectrum disorder; CCI, Charlson Comorbidity Index; ADL, activity of daily living.
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tions weakened in the period 1 month to 2 years (persistently 
low-ADL HR 1.73, 95% CI 1.52–1.96 and changed-ADL HR 
1.28 95% CI 1.13–1.47). Reflecting the strong correlation 
between the presence of CSD and functional decline (Table 1), 
adjustment by ADL status attenuated the associations between 
CSD and mortality; however, mortality risk in patients with 
CSD remained high showing similar temporal patterns to those 
before adjustment for ADL (Table S4, model c).
Table 2 Results of the non-proportional hazards model showing hazard ratio estimates of associations with mortality for people with 
CSD
CSD Time periods Hazard ratio and 95% CI
Unadjusted 
model (a)
Adjusted 
model (b)
Adjusted + 
ADL (c)
Delirium alone vs no CSD Up to 6 months 1.68 (1.48–1.90) 1.45 (1.28–1.65) 1.24 (1.08–1.42)
6 months to 1 year 1.25 (0.97–1.62) 1.07 (0.82–1.38) 0.94 (0.72–1.22)
1–2 years 1.69 (1.37–2.07) 1.44 (1.17–1.77) 1.27 (1.11–1.57)
Known dementia alone vs no CSD Up to 3 months 1.39 (1.14–1.70) 1.03 (0.84–1.28) 0.86 (0.69–1.07)
3 months to 2 years 2.39 (2.04–2.81) 1.85 (1.56–2.18) 1.55 (1.31–1.84)
Delirium and known dementia vs no CSD Up to 3 months 1.68 (1.39–2.03) 1.18 (0.96–1.45) 0.98 (0.80–1.20)
3 months to 2 years 2.48 (2.11–2.92) 1.80 (1.52–2.14) 1.49 (1.25–1.78)
Unspecified cognitive impairment vs no CSD Up to 6 months 1.54 (1.23–1.93) 1.11 (0.87–1.40) 0.97 (0.77–1.21)
6 months to 2 year 2.20 (1.72–2.82) 1.55 (1.21–1.99) 1.35 (1.05–1.74)
Abbreviations: CSD, cognitive spectrum disorder; ADL, activity of daily living.
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Figure 2 Changes in hazard ratio estimates over time unadjusted and adjusted for demographics, comorbidity variables (adjusted), and ADL functional status (adjusted + 
ADL), for the different types of CSD.
Abbreviations: CSD, cognitive spectrum disorder; ADL, activity of daily living.
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The sensitivity analysis conducted on the complete cases 
to account for the effect of missing ADL showed a general 
agreement between the survival models performed on the 
imputed data (Table S4, model c) and the complete cases 
data (Table S5). The HR estimates obtained from the model 
fitted to the imputed data are comparable to the HR estimates 
obtained from the complete cases data with the exception 
of HR estimates for patients with delirium after 1 year from 
admission. When applied to the complete cases only, the non-
proportional survival model adjusted for ADL indicated that 
patients admitted with delirium are not at an increased risk 
of death after 6 months from admission until the 2-year end 
of follow-up time (HR =1.14, 95% CI =0.90–1.45), whereas 
based on the imputed data set, this group of patients are still 
at risk between the 1 year and 2 years follow-up time (HR 
=1.27, 95% CI =1.11–1.57), a result which is consistent with 
the results of the unadjusted model, or the model adjusted 
for demographics and comorbidity only (models a and b in 
Table 2).
Comparing mortality risks among the 
different types of CSD
HR estimates comparing mortality among the different 
CSD groups are presented in Table S6. The survival model 
adjusted for demographic characteristics, residence status, 
and comorbidities showed that patients who were admitted 
with delirium alone had an increased risk of death in the first 
3 months following admission than patients with delirium 
superimposed on dementia (HR =1.30, 95% CI 1.06–1.59), 
the situation being completely reversed after 3 months in 
these two groups of patients (HR =0.72, 95% CI 0.59–0.86). 
In turn, mortality risk associated with delirium superimposed 
on dementia was not different from dementia alone for the 
whole follow-up time (HR =1.05, 95% CI 0.84–1.23). More-
over, patients admitted with an unspecified form of cognitive 
impairment had a reduced risk of death compared to patients 
with known dementia alone in the period between 3 and 6 
months from admission (HR =0.60, 95% CI 0.36–0.99).
Discussion
In this study, over a third of people aged ≥65 years with 
an incident admission to the AMU had a CSD, of which 
more than half died in the 2 years after admission. People 
with CSD at the time of admission had a higher mortality 
than people without CSD, which is not explained by dif-
ferences in age, sex, comorbidity, care home residence, or 
functional status. The study found that the risk of death was 
not constant over the 2-year follow-up time but varied with 
the underlying CSD condition; compared to people without 
CSD, those with delirium have an increased risk of death in 
the short term following admission, while people admitted 
with delirium superimposed on dementia, dementia alone, or 
unspecified cognitive impairment have increased medium- to 
longer-term risk.
These findings are consistent with Inouye’s concept that 
delirium occurs in the face of both precipitating and predis-
posing factors.30 We can postulate that patients with delirium 
alone are on average more severely ill from precipitating fac-
tors such as a physical illness causing the delirium resulting 
in increased early risk of death. Those with delirium super-
imposed with dementia have a worse 2-year prognosis overall 
in this study (Figure 1A), but after adjustment for baseline 
variables, their mortality is similar to that of patients with 
dementia alone. We can postulate that their predisposition 
to delirium as a result of existing dementia means that they 
require a smaller insult from physical illness (ie, less severe 
physical illness) to result in delirium, and their mortality 
remains that of their underlying dementia, comorbidity, and 
functional status.
Strengths and limitations
An important strength of the study is the examination of all 
types of CSD in a large, unselected population of people aged 
≥65 years admitted to hospital as a medical emergency who 
received a structured cognitive assessment on admission, and 
with complete 2-year follow-up of mortality after admission 
using linked data from routine clinical practice. The study 
included 6,724 incident patients with a new episode of acute 
hospital care, which is more than the total patients in all 
studies included in the most recent systematic reviews of 
dementia31 and delirium32 in hospital inpatients. The study is 
novel in its use of a non-proportional hazards survival model 
to account for the widespread violation of the proportional 
hazards assumption. Although we do not know whether 
previous studies used models that violated this assump-
tion because they do not discuss model assumptions, one 
explanation for inconsistencies in findings is that averaging 
hazards that are changing over time may lead to misleading 
findings (see Table S3). The patients in our study had a long 
post-admission follow-up time; however, the use of the non-
proportional hazards model allowed appropriate estimation 
of short- and long-term risk of mortality associated with the 
different type of CSD, information that is critical to health 
carers to appropriately manage this group of inpatients.
The main limitation is that all admissions were based 
within the same health care system, which may limit gener-
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alizability although this is true of most previous studies. In 
addition, by design OPRAA assessment was not offered to 
patients with brief admissions or patients who were critically 
ill, meaning that only 72% of incident admissions in the study 
period were included. Again though, this is similar to most 
consented research cohorts which often exclude patients who 
are admitted for <24 hours and which have similar propor-
tions of all admissions included.2 Of those patients who did 
not undergo an OPRAA assessment (n=2,600), 1,788 (68.8%) 
had a length of stay ≤2 days, 177 (6.8%) died within 1 month, 
and 758 (29.2%) died within 2 years. Mortality in the group 
of patients who did not undergo an OPRAA assessment is 
slightly lower compared to the OPRAA group; however, 
given the fact that the large majority of patients underwent 
an OPRAA assessment, the impact of those who did not 
undergo an OPRAA assessment on prevalence and outcomes 
will not be strong. Additionally, 27% of OPRAA patients 
had missing data for functional status. Multiple imputation 
was used to impute the missing values assuming data were 
missing at random. Missingness in the ADL may be related 
to a short length of stay or patients being in a critical state 
during admission resulting in a poor outcome, in which case 
the missing at random assumption may not be valid. However, 
the complete case sensitivity analysis showed good agree-
ment with the main analysis. Another limitation of the study 
relates to the fact that information on the marital status of the 
patient or living arrangements was not available in this study. 
These characteristics might act as potential confounding, 
although evidence from previous studies is mixed regarding 
the associations between these factors and mortality.16,19 Like 
all observational data analyses, we cannot rule out residual 
confounding as an explanation for the observed results.
Other limitations of the OPRAA cohort5 arise from: 
1) accuracy of brief assessment tools, 2) cross-sectional 
nature of assessment, and 3) lack of full dementia diagnos-
tic workup. The OPRAA assessment used relatively simple 
instruments suitable for identifying delirium and cognitive 
impairment in a routine clinical context which may not always 
match assessment using gold-standard research instruments 
but do reflect real-world practice.
Comparison to other studies
A number of previous studies have examined mortality in 
hospitalized people with CSD. Some studies on delirium16.20,33 
have reported significant associations between delirium and 
mortality at 1 year, whereas others have identified significant 
associations with short-term mortality19,34 but not at 1 year.35,36 
Evidence is also mixed regarding people with dementia, 
with some studies reporting short-2 or long-term19 increased 
mortality, while others found no association.35,36 Cognitive 
impairment in the absence of delirium or dementia has been 
less investigated. Evidence suggests that people admitted 
with moderate cognitive impairment are not at an increased 
risk of death in the short-term after admission,2,36 but no 
studies have longer-term follow-up. In contrast, mortality in 
people admitted with delirium superimposed on dementia has 
received extensive attention.16,17,19,33,35–37 Some studies have 
found no association with mortality at 1-year follow-up,13,26 
whereas others found a significantly higher mortality.19,35,36 
Explanations for this conflicting evidence include misclas-
sification due to the difficulty of diagnosing delirium in the 
context of dementia16,19 and small sample sizes or recruitment 
from narrow clinical populations in some studies.35 How-
ever, an alternative explanation is that none of these studies 
examined whether mortality risks vary over time with CSD 
violating the proportional hazards assumption, meaning that 
averages are potentially misleading.
Functional decline has been identified as an important 
outcome in people with CSD,18,20,36 but there is no consensus 
on whether functional impairment explains worse mortality 
in people with CSD.16,19 Interpretation is complicated by CSD 
being an important cause of reduced functional ability. Hence, 
adjusting for ADL may simultaneously appropriately account 
for higher physical comorbidity and frailty in people with 
CSD and potentially over-adjust the effect of CSD on mortal-
ity. However, after adjustment for ADL, we found that CSD 
was still independently associated with increased mortality.
Conclusion
One-third of medical inpatients have a CSD at admission 
and form a highly vulnerable population. Half will die in 
the 2 years after admission. Notably, after adjustment, hav-
ing delirium alone is associated with higher early mortality 
during the 6 months after admission, whereas dementia 
(alone or with delirium superimposed) had no early increase 
in mortality but did have higher mortality after 3 months and 
unspecified cognitive impairment only after 6 months. The 
findings are suggestive that those with unspecified cogni-
tive impairment may have early or undiagnosed dementia 
requiring follow-up after discharge to clarify diagnosis and 
optimize care. Additionally, this study does not support previ-
ous suggestions that delirium superimposed on dementia is 
associated with particularly poor prognosis, after adjusting 
for age and other covariates. This would be consistent with 
the role that established dementia plays as a predisposing 
factor for delirium onset, meaning that delirium in patients 
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with dementia occurs with less severe physical disease 
precipitating factors and therefore that dementia rather than 
delirium dominates associations with mortality. In turn, in the 
absence of dementia, individuals require a larger acute insult 
in order to precipitate delirium, being more acutely unwell at 
the time of their delirium onset. Further research to explain 
the mortality patterns observed is required.
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